EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access

Transvaginal Electrical Stimulation for Treatment of Overactive Bladder Without Incontinence: A Pilot Cross‐Over Clinical Trial

Michele Torosis, Lynn Stothers, Crystal Cisneros, Georgina Dominique, A Lenore Ackerman

Neurourology and Urodynamics · 2025

DOI: 10.1002/nau.70034 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Neurourology and Urodynamics, 2025. Verfasst von Michele Torosis und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, David Geffen School of Medicine at UCLA, Division of Urogynecology and Reconstructive Pelvic Surgery, Los An…. Hauptthemen laut MEDLINE: Urinary Bladder, Overactive, Urinary Bladder, Electric Stimulation Therapy. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCATS NIH HHS, Research reported in this study was supported by the National Center for Advancing Translational Science (NCATS) of the National Institutes of Health under the….

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

Few studies look at therapeutic efficacy specifically in the OAB population that lacks urgency incontinence (OAB‐dry). Transvaginal electrical stimulation (TES) improves urgency incontinence in OAB‐wet by targeting the detrusor muscle by reflex inhibition but has not yet been trialed for the improvement of urgency and frequency symptoms alone without incontinence. This study sought to measure the efficacy of an at‐home TES program on urgency and frequency symptoms alone in OAB‐dry.

Methods

This was a prospective, randomized, cross‐over, controlled trial of women > 18 years old presenting to a urogynecology clinic with urinary urgency and frequency without incontinence. Participants were randomized to receive 4 weeks of sham, followed by a 3‐week washout period, and then 4 weeks of intervention (Arm 1), or the reverse (Arm 2). Intervention included 15 min/day of TES using a TENS unit and transvaginal probe with stimulation width of 100 µs, rate of 12 Hz, and amplitude set by participant based on sensation. Baseline bladder symptoms were captured with voiding diaries and standardized questionnaires. Standardized pelvic floor muscle exam was performed at the beginning and end of treatment. Participants were categorized as responders if the participants stated they planned to continue the TES as their primary treatment after study completion. Outcomes were compared using t ‐tests, χ 2 , and Fisher exact tests.

Results

In total, 19 enrolled and 15 (79%) completed the study and had primary outcomes data available for analysis. There were no demographic differences between arms. Mean OAB‐q scores for all at baseline was 25.1, post‐sham was 22.9, and post‐TES was 17.60, for a mean change of −7.73 points (95% CI, −21.5 to 5.9), p = 0.007). There was a reduction in voids per 24 h from 11.3 (± 3.7) to 9.0 (± 3.6) posttreatment ( p = 0.048). Response, defined as continuation of therapy, had a significant association with lack of pelvic floor tenderness on baseline standardized exam (OR 0.96, CI 0.94–0.99).

Conclusions

These data suggest there are two phenotypes within OAB‐dry, those with pelvic floor myofascial dysfunction that do not respond to bladder directive therapy, and those who represent a population of less severe OAB‐wet with detrusor overactivity, which respond to bladder directive therapy. TES is a viable treatment option for this population, resulting in clinically significant improvements in urinary symptoms and patient‐reported disease severity. Trial Registration: ClinicalTrials.gov : NCT04957524.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Urinary Bladder, OveractiveUrinary BladderElectric Stimulation TherapyHumansFemaleMiddle AgedCross-Over StudiesPilot ProjectsTreatment OutcomeProspective StudiesVaginaAgedAdultUrodynamics

Stichwörter der Autor:innen

electrical stimulationhigh tone pelvic floor disorderneuromodulationoveractive bladderurinary urgency

Autor:innen und Institutionen

  • Department of Obstetrics and Gynecology, David Geffen School of Medicine at UCLA, Division of Urogynecology and Reconstructive Pelvic Surgery, Los Angeles, California, USA.
  • Department of Urology, David Geffen School of Medicine at UCLA, Division of Urogynecology and Reconstructive Pelvic Surgery, Los Angeles, California, USA.

Förderung

  • NCATS NIH HHS
  • Research reported in this study was supported by the National Center for Advancing Translational Science (NCATS) of the National Institutes of Health under the…

Zitieren

APA

Torosis, M., Stothers, L., Cisneros, C., Dominique, G., & Lenore Ackerman, A. (2025). Transvaginal Electrical Stimulation for Treatment of Overactive Bladder Without Incontinence: A Pilot Cross‐Over Clinical Trial. Neurourology and Urodynamics. https://doi.org/10.1002/nau.70034

Vancouver

Torosis M, Stothers L, Cisneros C, Dominique G, Lenore Ackerman A. Transvaginal Electrical Stimulation for Treatment of Overactive Bladder Without Incontinence: A Pilot Cross‐Over Clinical Trial. Neurourology and Urodynamics. 2025. doi:10.1002/nau.70034

BibTeX
@article{Torosis2025,
  author = {Torosis, Michele and Stothers, Lynn and Cisneros, Crystal and Dominique, Georgina and Lenore Ackerman, A},
  title = {Transvaginal Electrical Stimulation for Treatment of Overactive Bladder Without Incontinence: A Pilot Cross‐Over Clinical Trial},
  journal = {Neurourology and Urodynamics},
  year = {2025},
  doi = {10.1002/nau.70034}
}
Kostenlos starten →